J&J Gives AIDS Drug Rights to Charity for Vaginal RingSimeon Bennett
Johnson & Johnson gave the rights to an experimental AIDS drug to a charity that’s testing the medicine in a vaginal ring to prevent HIV infection.
J&J gave the global rights to develop and market dapivirine to the International Partnership for Microbicides, a Silver Spring, Maryland-based organization that works on developing HIV prevention tools for women, IPM said today in a statement.
The agreement expands a previous partnership in which IPM held the drug rights for developing nations. The group is testing dapivirine in a vaginal ring in two late-stage studies in Africa and may in the future combine the drug with contraceptives.
“Women are in a race against time for new HIV prevention methods and they need innovative tools to protect themselves,” Zeda Rosenberg, IPM’s chief executive officer, said in the statement.